The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3β in hepatocellular carcinoma

Journal of Hepatology

Volumn 40, Issue 2, 2004, Pages 212-218

  Vavricka, Stephan R ^a   Jung, Diana ^a   Fried, Michael ^a   Grützner, Uwe ^b   Meier, Peter J ^a   Kullak Ublick, Gerd A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Hepatocellular carcinoma; Hepatocyte nuclear factor 3 ; Human organic anion transporting polypeptide 8

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3; ISOPROTEIN; LUCIFERASE; MESSENGER RNA; ORGANIC ANION TRANSPORTER; PEPTIDE DERIVATIVE; POLYPEPTIDE; PROTEIN SUBUNIT; RNA; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BINDING SITE; CANCER TISSUE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SAMPLING; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 1642491778     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2003.10.008     Document Type: Article

References (40)

1. Hagenbuch B., Meier P.J. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta. 1609:2003;1-18.
2. Kullak-Ublick G.A., Stieger B., Hagenbuch B., Meier P.J. Hepatic transport of bile salts. Semin Liver Dis. 20:2000;273-292.
3. Abe T., Kakyo M., Tokui T., Nakagomi R., Nishio T., Nakai D., et al. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 274:1999;17159-17163.
4. Hsiang B., Zhu Y., Wang Z., Wu Y., Sasseville V., Yang W.-P., et al. A novel human hepatic organic anion transporting polypeptide (OATP2). J Biol Chem. 274:1999;37161-37168.
5. König J., Cui Y., Nies A.T., Keppler D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol. 278:2000;G156-G164.
6. Kullak-Ublick G.A., Ismair M.G., Stieger B., Landmann L., Huber R., Pizzagalli F., et al. Organic anion transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 120:2001;525-533.
7. Cui Y., König J., Leier I., Buchholz U., Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 276:2001;9626-9630.
8. König J., Cui Y., Nies A.T., Keppler D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 275:2000;23161-23168.
9. Ismair M.G., Stieger B., Cattori V., Hagenbuch B., Fried M., Meier P.J., et al. Hepatic uptake of cholecystokinin octapeptide by organic anion transporting polypeptides Oatp4 and OATP8 of rat and human liver. Gastroenterology. 121:2001;1185-1190.
10. Abe T., Unno M., Onogawa T., Tokui T., Kondo T.N., Nakagomi R., et al. Lst-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 120:2001;1689-1699.
11. Jung D., Hagenbuch B., Gresh L., Pontoglio M., Meier P.J., Kullak-Ublick G.A. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1α J Biol Chem. 276:2001;37206-37214.
12. Jung D., Kullak-Ublick G.A. Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression. Hepatology. 37:2003;622-631.
13. Jung D., Podvinec M., Meyer U.A., Mangelsdorf D.J., Fried M., Meier P.J., et al. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology. 122:2002;1954-1966.
14. Karpen S.J., Sun A.-Q., Kudish B., Hagenbuch B., Meier P.J., Ananthanarayanan M., et al. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. J Biol Chem. 271:1996;15211-15221.
15. Rausa F.M., Tan Y., Zhou H., Yoo K.W., Stolz D.B., Watkins S.C., et al. Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol. 20:2000;8264-8282.
16. Tan Y., Hughes D., Wang X., Costa R.H. Adenovirus-mediated increase in HNF-3beta or HNF-3alpha shows differences in levels of liver glycogen and gene expression. Hepatology. 35:2002;30-39.
17. Xu L., Hui L., Wang S., Gong J., Jin Y., Wang Y., et al. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res. 61:2001;3176-3181.
18. Kaestner K.H. The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol Metab. 11:2000;281-285.
19. Pani L., Overdier D.G., Porcella A., Qian X., Lai E., Costa R.H. Hepatocyte nuclear factor 3β contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein. Mol Cell Biol. 12:1992;3723-3732.
20. Schrem H., Klempnauer J., Borlak J. Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev. 54:2002;129-158.
21. Vallet V., Antoine B., Chafey P., Vandewalle A., Kahn A. Overproduction of a truncated hepatocyte nuclear factor 3 protein inhibits expression of liver-specific genes in hepatoma cells. Mol Cell Biol. 15:1995;5453-5460.
22. Cui Y., König J., Nies A.T., Pfannschmidt M., Hergt M., Franke W.W., et al. Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab Invest. 83:2003;527-538.
23. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
24. Zaret K.S. Molecular genetics of early liver development. Annu Rev Physiol. 58:1996;231-251.
25. Sund N.J., Ang S.L., Sackett S.D., Shen W., Daigle N., Magnuson M.A., et al. Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte. Mol Cell Biol. 20:2000;5175-5183.
26. Ang S.L., Rossant J. HNF-3 beta is essential for node and notochord formation in mouse development. Cell. 78:1994;561-574.
27. Dufort D., Schwartz L., Harpal K., Rossant J. The transcription factor HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis. Development. 125:1998;3015-3025.
28. Duncan S.A., Navas M.A., Dufort D., Rossant J., Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science. 281:1998;692-695.
29. Stenson-Cox C., McNair A., Curley M., Smith T., Gannon F. A role for HNF-3 in the regulation of the HNF-1 gene of the Atlantic salmon. Mol Genet Genomics. 266:2002;832-837.
30. Philippe J., Morel C., Prezioso V.R. Glucagon gene expression is negatively regulated by hepatocyte nuclear factor 3 beta. Mol Cell Biol. 14:1994;3514-3523.
31. Gregori C., Kahn A., Pichard A.L. Activity of the rat liver-specific aldolase B promoter is restrained by HNF3. Nucleic Acids Res. 22:1994;1242-1246.
32. Cooper A.D., Chen J., Botelho-Yetkinler M.J., Cao Y., Taniguchi T., Levy-Wilson B. Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7α-hydroxylase gene. J Biol Chem. 272:1997;3444-3452.
33. Kullak-Ublick G.A., Glasa J., Boeker C., Oswald M., Gruetzner U., Hagenbuch B., et al. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology. 113:1997;1295-1305.
34. Tirona R.G., Kim R.B. Pharmacogenomics of organic anion-transporting polypeptides (OATP). Adv Drug Deliv Rev. 54:2002;1343-1352.
35. van Montfoort J.E., Stieger B., Meijer D.K.F., Weinmann H.-J., Meier P.J., Fattinger K.E. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther. 290:1999;153-157.
36. Pascolo L., Cupelli F., Anelli P.L., Lorusso V., Visigalli M., Uggeri F., et al. Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun. 257:1999;746-752.
37. Monte M.J., Dominguez S., Palomero M.F., Macias R.I.R., Marin J.J.G. Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors. J Hepatol. 31:1999;521-528.
38. Dominguez M.F., Macias R.I., Izco Basurko I., de La Fuente A., Pascual M.J., Criado J.M., et al. Low in vivo toxicity of a novel cisplatin- ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors. J Pharmacol Exp Ther. 297:2001;1106-1112.
39. Larena M.G., Martinez Diez M.C., Monte M.J., Dominguez M.F., Pascual M.J., Marin J.J. Liver organotropism and biotransformation of a novel platinum-ursodeoxycholate derivative, Bamet-UD2, with enhanced antitumour activity. J Drug Target. 9:2001;185-200.
40. Briz O., Serrano M.A., Rebollo N., Hagenbuch B., Meier P.J., Koepsell H., et al. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum (II) and cis-diammine-bisursodeoxycholate-platinum (II) toward liver cells. Mol Pharmacol. 61:2002;853-860.